C
Chunfu Zheng
H指数:51
被引数:8,938
个人简介
Dr. Chunfu Zheng has been selected for Elsevier's Top 0.5% (2023) and Top 1% (2021-2022) scientists and is an Adjunct Professor at the University of Calgary (https://cumming.ucalgary.ca/departments/microinfect/chunfu-zheng), Calgary, Canada. Dr. Zheng's research is internationally recognized for his contributions to antiviral innate immunity to herpesviruses, such as herpes simplex virus type 1/2 and varicella-zoster virus, and viral immune evasion mechanisms. Dr. Zheng has published more than 120 peer-reviewed biomedical research articles in prestigious journals such as mBio, Journal of Virology (28 papers, including 1 cover story and 2 spotlighted feature papers), Lancet Microbe (2 papers), Trends in Microbiology (2 papers), Microbiology and Molecular Biology Reviews (Cover story), FEMS Microbiology Reviews, Blood, Cytokine & Growth Factor Reviews, Reviews in Medical Virology, Cellular and Molecular Life Sciences, and Journal of Immunology. He earned his Ph.D. in Medical Sciences from Chongqing Medical University, China, and completed postdoctoral training at the University of Saskatchewan and University of Calgary in Canada. Before joining Fujian Medical University, Dr. Zheng was a Professor at Wuhan Institute of Virology, Chinese Academy of Sciences, and Soochow University, China. Dr. Zheng has earned numerous awards and distinctions, including the Hundred-Talent Program of the Chinese Academy of Sciences, the top 25 reviewers for the Journal of Virology (2019, 2020, 2021, 2022), the Publons Top 1% peer reviewers (2019-2020), and excellent editors of ASM (mBio), Springer Nature and Frontiers. Dr. Zheng serves as an editor of mBio, an Associate Editor of Virology Journal, etc.
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
- Elsevier's Top 0.5% (2023)(2023)|Elsevier
- Hundred-Talent Program of the Chinese Academy of Sciences|Chinese Academy of Sciences
- top 25 reviewers for the Journal of Virology|Journal of Virology
- Publons Top 1% peer reviewers(2019-2020)|Publons
- excellent editors of ASM (mBio), Springer Nature and Frontiers|ASM (mBio), Springer Nature and Frontiers
固有免疫介导的炎症和HSV-1感染
病毒免疫逃逸与MHC I类抗原处理通路之间的竞赛
当微RNA遭遇缺氧性肺动脉高压
糖基化作为RLR和cGAS-STING先天免疫信号通路的动态调节剂
PARP1通过p38-related反馈调节稳定FOXN3抑制肺纤维化
SCIENCE ADVANCES
IF12.5
更正:VZV IE4通过将其隔离到高尔基复合体来下调细胞表面MHC-I。
经血源性间充质干细胞来源的外泌体通过抑制NF-κB信号通路抑制炎性动脉粥样硬化
BMC Medicine
IF8.3
靶向NLRP3-ROS轴:破坏颅内出血中的氧化-炎症恶性循环
CELLULAR SIGNALLING
IF3.7
Palmitoyl-transferase 3 通过调控其泛素化促进线粒体抗病毒信号蛋白的降解。
RTA通过miR-155/GATA3/STAT3调控网络激活miR-155启动子区域的活性,并促进内皮细胞的生长和侵袭。
当COVID-19遇到糖尿病:一项文献计量分析
阿兹夫定治疗效果与安全性的进展:一项综合综述
当糖生物学与炎症小体激活相遇:见解与意义
MAVS: 癌症和其他疾病的下一个刺痛
VZV IE4通过将其隔离到高尔基复合体来下调细胞表面mhc-i

